Sign In
Buy CDXS
$2.72
+0.0300 (+1.12%)
At Close: Jun 03, 2026
Edited Transcript of CDXS earnings conference call or presentation 7-May-20 8:30pm GMT
06:13pm, Friday, 08'th May 2020
Q1 2020 Codexis Inc Earnings Call
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Codexis Q1 EPS $(0.090) Beats $(0.140) Estimate, Sales $14.700M Beat $13.250M Estimate
08:46pm, Thursday, 07'th May 2020Codexis Reports First Quarter 2020 Financial Results
08:05pm, Thursday, 07'th May 2020
R&D; revenue increased 26% to $9.6 million fueled by the Novartis and Takeda strategic collaborations Withdraws 2020 financial guidance due to uncertainty of COVID-19.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Codexis Reports Achieved Wave 2 Milestone Associated With CodeEvolver Platform, License Deal With Novartis
08:27pm, Wednesday, 06'th May 2020Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader
08:05pm, Wednesday, 06'th May 2020
Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone associated with the CodeEvolver® platform technology transfe
Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
11:00am, Tuesday, 05'th May 2020
Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as Senior Vice President, Research and Karl A. Schoene, Ph.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Codexis (NASDAQ:CDXS) Downgraded to "Buy" at ValuEngine
05:42am, Saturday, 02'nd May 2020
Codexis (NASDAQ:CDXS) was downgraded by equities researchers at ValuEngine from a “strong-buy” rating to a “buy” rating in a report released on Friday, ValuEngine reports. A number of other eq
Codexis to Hold First Quarter 2020 Conference Call on May 7
11:00am, Thursday, 30'th Apr 2020
REDWOOD CITY, Calif., April 30, 2020 -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results.
Earnings Preview: Codexis (CDXS) Q1 Earnings Expected to Decline
04:31pm, Monday, 27'th Apr 2020
Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Codexis (CDXS) Q1 Earnings Expected to Decline
04:31pm, Monday, 27'th Apr 2020
Codexis (CDXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
We’re Hopeful That Codexis (NASDAQ:CDXS) Will Use Its Cash Wisely
12:19pm, Monday, 27'th Apr 2020
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
